Bymetric
UK company intelligence
Company Active LTD

Company profile

Nanogenics Limited

Nanogenics - Delivering Gene Therapy

Nanogenics Limited is a UK company with status active founded in 2011 based in London.

CRN
07636591
Founded
2011
Age
15

Overview

Legal name
NANOGENICS LIMITED
Region
London
Registered address
C/O ARCH LAW LEVEL 2 HUCKLETREE
8 BISHOPSGATE
LONDON
UNITED KINGDOM
EC2N 4BQ
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

1 level 1 ultimate controller
1
Company Active LTD
Nanogenics Limited
CRN 07636591
2
Direct and ultimate controller Active PLC
N4 Pharma PLC
CRN 01435584

Company events

Reference milestones and recent Companies House filing stream events.

6 events
30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

22 Jul
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

08 Jul
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

06 Oct
2024

Accounts With Accounts Type Micro Entity

Accounts PDF pending

AA | Transaction MzQzNzk0OTQyMGFkaXF6a2N4 | Paper/PDF filed

Published 07 Oct 2024 05:38

17 May
2011

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2019
Funded years
2019
Age at first award
8 years

Projects

2019 Collaborative R&D Lead participant

Development of a breakthrough anti-fibrotic gene therapy to improve surgical outcomes and reduce re-admission rates for patients with severe glaucoma.

1 Nov 2019 to 31 Jan 2021

Awarded
£346,254
Total cost £494,648

Lifetime risk of permanent sight loss or blindness was estimated to be 1/5 of people globally (DeloitteAccessEconomics-2017). \>2M people(UK) live with sight loss significant enough to have a drastic impact upon their daily lives, with the cost estimated at £28.1Bn (RNIB-2017). Glaucoma is the second leading cause of blindness, with 500,000 UK residents a...

Product types

Collaborative R&D